Glovista Investments’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-39,233
Closed -$5.53M 78
2021
Q4
$5.53M Buy
39,233
+36,172
+1,182% +$4.8M 1.53% 19
2021
Q3
$390K Buy
+3,061
New +$405K 0.11% 53
2020
Q4
Sell
-26,552
Closed -$2.8M 131
2020
Q3
$2.8M Buy
+26,552
New +$2.79M 0.99% 29
2019
Q2
Sell
-4,351
Closed -$399K 103
2019
Q1
$399K Buy
+4,351
New +$392K 0.13% 63
2017
Q4
Sell
-252,996
Closed -$20.7M 123
2017
Q3
$20.7M Buy
+252,996
New +$20.3M 3.95% 7

Other funds holding XLV

Glovista Investments's XLV Position: Q1 2022 in Review

Glovista Investments sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2022, closing a stake of 39,233 shares — an estimated $5.53M sold.

Glovista Investments first reported a position in XLV in Q3 2017 and held it in 5 quarters. The position peaked at $20.7M in Q3 2017. 1,439 funds tracked by Wall St. Rank hold XLV as of Q1 2022.

  • Glovista Investments reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2022 after selling out during the quarter.
  • Glovista Investments sold 39,233 State Street Health Care Select Sector SPDR ETF shares in Q1 2022, an estimated $5.53M.
  • Glovista Investments first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2017 and held it in 5 quarters.
  • Glovista Investments's State Street Health Care Select Sector SPDR ETF position peaked at $20.7M in Q3 2017.
  • 1,439 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2022.

Based on Glovista Investments's 13F filing for Q1 2022, filed 16 May 2022.